Clinical Trials
48 trialsINSPIRE
Singlera Genomics Inc.
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Kalbe International Pte. Ltd
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Shanghai Bovax Biotechnology Co., Ltd.
Study of ZG005 in Combination With Paclitaxel+Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood
WomenX Biotech Limited
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine
WomenX Biotech Limited
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
HRYZ Biotech Co.
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
Shanghai Huaota Biopharmaceutical Co., Ltd.
Sirius in Gynaecological Laparoscopic Surgery
Precision Robotics (Hong Kong) Limited
AL3818
Advenchen Laboratories, LLC
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Chongqing Precision Biotech Co., Ltd
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
Chongqing Precision Biotech Co., Ltd
A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.
Precision Robotics (Hong Kong) Limited
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
Shanghai Yunying Medical Technology
Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences
Power Life Sciences Inc.
VALTRIHP
Hiantis Srl
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
Qilu Pharmaceutical Co., Ltd.
Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
Shanghai Zerun Biotechnology Co.,Ltd
A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer
Qilu Pharmaceutical Co., Ltd.
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer
Qilu Pharmaceutical Co., Ltd.
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
Jiangsu HengRui Medicine Co., Ltd.
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
Corregene Biotechnology Co., Ltd
A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy
Shanghai Henlius Biotech
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
GLUCANCIN
Uriach Consumer Healthcare
GLUCANVIR
Uriach Consumer Healthcare
A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors
Hebei Senlang Biotechnology Inc., Ltd.
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Recurrent or Metastatic Cervical Cancer
Lee's Pharmaceutical Limited
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive
Genor Biopharma Co., Ltd.
TILs for Treatment of Metastatic or Recurrent Cervical Cancer
Shanghai OriginCell Therapeutics Co., Ltd.
PIONEER
SpeciCare
A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
FERMATA
Biocad
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
MultiVir, Inc.
Biop System's Safety and Performance
BIOP Medical
V3-Cervix
Immunitor LLC
CC
Guangzhou Gloria Biosciences Co., Ltd.
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)
Biocad
COTI2-101
Critical Outcome Technologies Inc.
DNA Methylation Biomarkers for Cervical Cancer Screening
iStat Biomedical CO., Ltd.
Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females
Shanghai Zerun Biotechnology Co.,Ltd
oncoFISH Cervical Test for Detection of 3q26 Region Gain
Ikonisys, Inc.
Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer
Onconix, Inc